Jason Bassetti
Lawyers
Filters
Revolution Medicines $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
TaskUs upsized $766.9 million follow-on offering
We advised the underwriters on the secondary offering
RxSight $117.6 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Xponential Fitness $120 million IPO and $200 million convertible offering
We advised Xponential Fitness on its concurrent IPO, NYSE listing and convertible preferred offering
Acutus Medical $77 million follow-on offering
We advised Acutus Medical on the SEC-registered stock offering
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Ultra Clean $175 million follow-on offering
We advised Ultra Clean on its SEC-registered equity offering
Ultra Clean acquisition of Ham-Let and related financing
We advised Ultra Clean on the acquisition and related financing
Avid Bioservices $143.8 million exchangeable senior notes offering
We advised the initial purchasers on the Rule 144A offering
Doma $3 billion business combination with Capitol Investment Corp. V
We are advising Doma on its combination with Capitol, a SPAC